Yonghe Medical Group Co., Ltd. provided consolidated earnings guidance for the six months ended June 30, 2023. The board of directors of the company inform the shareholders of the company and potential investors of the company that, based on a preliminary review of the unaudited consolidated management accounts of the Group for the six months ended June 30, 2023 and the information currently available to the Board, the Group expects to record a net loss of not more than RMB 240.0 million for the six months ended June 30, 2023, as compared with the net profit of RMB 17.6 million for the six months ended June 30, 2022.